Dr. Jolissaint is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1275 York Avenue
New York, NY 10065- Is this information wrong?
Education & Training
- Cornell UniversityMSc, Clinical and Translational Investigation, 2019 - 2021
- University of Virginia School of MedicineClass of 2016, MD
- University of VirginiaBA, Chemistry, Psychology, 2007 - 2011
Certifications & Licensure
- MA State Medical License 2016 - 2025
- NY State Medical License 2023 - 2025
- American Board of Surgery Surgery
Publications & Presentations
PubMed
- ASO Visual Abstract: Gemcitabine with Cisplatin Versus Hepatic Arterial Infusion Pump Chemotherapy for Liver-Confined Unresectable Intrahepatic Cholangiocarcinoma.Stijn Franssen, Jessica J Holster, Joshua S Jolissaint, Lynn E Nooijen, Andrea Cercek, Michael I D'Angelica, Marjolein Y V Homs, Alice C Wei, Vinod P Balachandran, Jef...> ;Annals of Surgical Oncology. 2024 Feb 1
- Gemcitabine with Cisplatin Versus Hepatic Arterial Infusion Pump Chemotherapy for Liver-Confined Unresectable Intrahepatic Cholangiocarcinoma.Stijn Franssen, Jessica J Holster, Joshua S Jolissaint, Lynn E Nooijen, Andrea Cercek, Michael I D'Angelica, Marjolein Y V Homs, Alice C Wei, Vinod P Balachandran, Jef...> ;Annals of Surgical Oncology. 2024 Jan 1
- Hepatic disease control in patients with intrahepatic cholangiocarcinoma correlates with overall survival.Kevin C Soares, Joshua S Jolissaint, Sarah M McIntyre, Kenneth P Seier, Mithat Gönen, Carlie Sigel, Naaz Nasar, Andrea Cercek, James J Harding, Nancy E Kemeny, Louise ...> ;Cancer Medicine. 2023 Jun 1
- Join now to see all
Hospital Affiliations
- Memorial Sloan Kettering Cancer CenterNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: